GlassScriptPhysician profile
Darla M Rivera
NPI 1336149137
$8,774.66
in general payments reported to CMS, 2019-2025
58 companies · $976 in 2025
The $976 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $866 · 2020: $1,656 · 2021: $1,621 · 2022: $1,412 · 2023: $1,207 · 2024: $1,037 · 2025: $976.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,181 · Education: $38.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,181.00 |
| Education | $38.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,200.06 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,089.23 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $791.14 | 2019-2025 | |
| Abbvie INC. | $780.65 | 2020-2025 | Qulipta, Ubrelvy, Linzess |
| Amarin Pharma, INC. | $405.39 | 2019-2022 | |
| Amgen INC. | $335.06 | 2019-2025 | Evenity, Prolia, Prolia |
| Lilly USA, LLC | $315.95 | 2019-2025 | Mounjaro, Zepbound, Reyvow |
| Janssen Pharmaceuticals, INC | $313.73 | 2020-2022 | |
| Abbott Laboratories | $301.52 | 2019-2025 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $244.55 | 2019-2023 | |
| Allergan, INC. | $213.89 | 2020 | |
| Radius Health, INC. | $204.27 | 2019-2022 | |
| Astellas Pharma US INC | $191.45 | 2023-2025 | Veozah |
| Eisai INC. | $173.23 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $143.40 | 2019-2024 |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darla Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.